Back to UBS Group AG UBS Group AG

INKTINKT
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in MINK THERAPEUTICS INC

UBS Group AG holds 4,885 shares of INKT (MINK THERAPEUTICS INC), worth $57,106 as of 2026-Q2. The position was decreased (-67.9% shares).

Current Value

$57,106

Current Shares

4,885

Total Value Change

+$54,652

Total Shares Change

+4,601

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4,885
-67.9%
$57,1060.0%$11.69
0
2026-Q1
Increased
15,202
+59.2%
$160,0770.0%$10.64
22
2025-Q4
Increased
9,548
+69.0%
$106,4610.0%$11.32
22
2025-Q3
Increased
5,648
+1888.7%
$79,0720.0%$13.70
23
2025-Q2
Unchanged
284
0.0%
$2,0980.0%$6.98
0
2025-Q1
New
284
-
$2,4540.0%$9.03
19

Other major holders of INKT: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, DnB Asset Management AS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used